For more than 110 years, the Merz Group has challenged the status-quo with our innovative healthcare solutions to bring better outcomes to more patients. This philosophy originated with our founder – a young chemist and entrepreneur named Friedrich Merz – who always asked, ‘What is needed?’ This highly-focused approach continues to inspire our relentless pursuit to serve unmet patients’ needs around the world.
At Merz Therapeutics, a part of the Merz Pharmaceuticals GmbH and family-owned Merz Group, our dedication to helping patients achieve their individual goals is as much our legacy as it is our vision for the future. We seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. This spirit drove us to become one of the first companies to develop and commercialize a botulinum toxin. With our cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards.
Our patient-centric legacy fuels the passion in everything we do, as we actively collaborate with patients, healthcare providers, patient advocacy organizations, business partners and employees. Together, we define what is needed – to bring better outcomes to more patients.